Commerce Bank’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.49M | Sell |
7,647
-6,307
| -45% | -$1.31M | 0.01% | 643 |
|
|
2026
Q1 | $3.13M | Sell |
13,954
-363
| -3% | -$90.5K | 0.02% | 439 |
|
|
2025
Q4 | $3.45M | Sell |
14,317
-2,259
| -14% | -$578K | 0.02% | 372 |
|
|
2025
Q3 | $4.54M | Buy |
16,576
+111
| +0.7% | +$30.3K | 0.03% | 340 |
|
|
2025
Q2 | $4.25M | Buy |
16,465
+9,528
| +137% | +$2.27M | 0.03% | 344 |
|
|
2025
Q1 | $1.55M | Buy |
6,937
+489
| +8% | +$114K | 0.01% | 519 |
|
|
2024
Q4 | $1.47M | Buy |
6,448
+73
| +1% | +$17.6K | 0.01% | 533 |
|
|
2024
Q3 | $1.56M | Sell |
6,375
-234
| -4% | -$52.3K | 0.01% | 528 |
|
|
2024
Q2 | $1.27M | Buy |
6,609
+1,726
| +35% | +$350K | 0.01% | 562 |
|
|
2024
Q1 | $967K | Sell |
4,883
-18,115
| -79% | -$3.32M | 0.01% | 636 |
|
|
2023
Q4 | $3.96M | Sell |
22,998
-4,059
| -15% | -$624K | 0.03% | 349 |
|
|
2023
Q3 | $4M | Buy |
27,057
+7,340
| +37% | +$1.33M | 0.03% | 315 |
|
|
2023
Q2 | $4.31M | Buy |
19,717
+15,020
| +320% | +$3.35M | 0.03% | 313 |
|
|
2023
Q1 | $1.03M | Sell |
4,697
-12
| -0.3% | -$2.6K | 0.01% | 560 |
|
|
2022
Q4 | $980K | Sell |
4,709
-31
| -0.7% | -$6.81K | 0.01% | 566 |
|
|
2022
Q3 | $1.03M | Sell |
4,740
-94
| -2% | -$21.4K | 0.01% | 540 |
|
|
2022
Q2 | $1.01M | Buy |
4,834
+1,062
| +28% | +$226K | 0.01% | 565 |
|
|
2022
Q1 | $915K | Sell |
3,772
-173
| -4% | -$41.8K | 0.01% | 618 |
|
|
2021
Q4 | $1.03M | Buy |
3,945
+121
| +3% | +$31.4K | 0.01% | 619 |
|
|
2021
Q3 | $1.01M | Buy |
3,824
+531
| +16% | +$145K | 0.01% | 609 |
|
|
2021
Q2 | $812K | Buy |
3,293
+51
| +2% | +$10.7K | 0.01% | 677 |
|
|
2021
Q1 | $629K | Buy |
3,242
+53
| +2% | +$10.6K | ﹤0.01% | 735 |
|
|
2020
Q4 | $678K | Sell |
3,189
-52
| -2% | -$10.4K | 0.01% | 674 |
|
|
2020
Q3 | $555K | Sell |
3,241
-516
| -14% | -$95.3K | 0.01% | 657 |
|
|
2020
Q2 | $722K | Buy |
3,757
+728
| +24% | +$119K | 0.01% | 564 |
|
|
2020
Q1 | $446K | Buy |
3,029
+222
| +8% | +$35.4K | 0.01% | 626 |
|
|
2019
Q4 | $435K | Buy |
2,807
+1,232
| +78% | +$178K | ﹤0.01% | 691 |
|
|
2019
Q3 | $213K | Buy |
+1,575
| New | +$206K | ﹤0.01% | 878 |
|
|
2013
Q4 | – | Sell |
-8,192
| Closed | -$433K | – | 788 |
|
|
2013
Q3 | $433K | Hold |
8,192
| – | – | 0.01% | 508 |
|
|
2013
Q2 | $370K | Buy |
+8,192
| New | +$389K | 0.01% | 546 |
|
Other funds holding RMD
Commerce Bank's RMD Position: Q2 2026 in Review
Commerce Bank reduced its ResMed (RMD) stake by 45% in Q2 2026, selling an estimated $1.31M and leaving 7,647 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #643.
Commerce Bank first reported a position in RMD in Q2 2013 and has held it in 30 quarters since. The position peaked at $4.54M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Commerce Bank held 7,647 shares of ResMed worth $1.49M as of Q2 2026.
- Commerce Bank sold 6,307 ResMed shares in Q2 2026, an estimated $1.31M.
- ResMed made up 0.01% of Commerce Bank's portfolio in Q2 2026, its #643 holding.
- Commerce Bank first reported a position in ResMed in Q2 2013 and has held it in 30 quarters since.
- Commerce Bank's ResMed position peaked at $4.54M in Q3 2025.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.